tacrine has been researched along with Depressive Disorder in 2 studies
Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.
Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Riemann, D | 1 |
Hohagen, F | 1 |
Bahro, M | 1 |
Lis, S | 1 |
Stadmüller, G | 1 |
Gann, H | 1 |
Berger, M | 1 |
Vida, S | 1 |
Gauthier, L | 1 |
Gauthier, S | 1 |
2 trials available for tacrine and Depressive Disorder
Article | Year |
---|---|
Cholinergic neurotransmission, REM sleep and depression.
Topics: Adolescent; Adult; Aged; Alzheimer Disease; Brain Stem; Cholinergic Agonists; Cholinergic Fibers; De | 1994 |
Canadian collaborative study of tetrahydroaminoacridine (THA) and lecithin treatment of Alzheimer's disease: effect on mood.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aminoacridines; Clinical Trials as Topic; Depressive Dis | 1989 |